Aquestive Therapeutics
AQST
AQST
57 hedge funds and large institutions have $48.1M invested in Aquestive Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 47 → 57 (+10)
1.42% more ownership
Funds ownership: 34.24% → 35.66% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
57
Holding in Top 10
3
Calls
$339K
Puts
$86K
Top Buyers
| 1 | +$1.71M | |
| 2 | +$688K | |
| 3 | +$385K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$334K |
| 5 |
Jane Street
New York
|
+$315K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$537K | |
| 3 | -$264K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$154K |
| 5 |
Millennium Management
New York
|
-$125K |